Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 3,000
- Avg volume
- —
- Day's range
- $0.16 – $0.16
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distr...
Show more
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.
- Industry
- Beverages - Non-Alcoholic
- Sector
- Consumer Defensive
- Phone
- 800 341 8940
- Address
- 954 Lexington Avenue, Suite 505, New York, United States
Latest news
No headlines yet.
